Literature DB >> 28652336

Structure of human nSMase2 reveals an interdomain allosteric activation mechanism for ceramide generation.

Michael V Airola1,2, Prajna Shanbhogue2, Achraf A Shamseddine3, Kip E Guja4, Can E Senkal1,3, Rohan Maini2, Nana Bartke5,6, Bill X Wu6, Lina M Obeid1,3,7, Miguel Garcia-Diaz4, Yusuf A Hannun8,2,3.   

Abstract

Neutral sphingomyelinase 2 (nSMase2, product of the SMPD3 gene) is a key enzyme for ceramide generation that is involved in regulating cellular stress responses and exosome-mediated intercellular communication. nSMase2 is activated by diverse stimuli, including the anionic phospholipid phosphatidylserine. Phosphatidylserine binds to an integral-membrane N-terminal domain (NTD); however, how the NTD activates the C-terminal catalytic domain is unclear. Here, we identify the complete catalytic domain of nSMase2, which was misannotated because of a large insertion. We find the soluble catalytic domain interacts directly with the membrane-associated NTD, which serves as both a membrane anchor and an allosteric activator. The juxtamembrane region, which links the NTD and the catalytic domain, is necessary and sufficient for activation. Furthermore, we provide a mechanistic basis for this phenomenon using the crystal structure of the human nSMase2 catalytic domain determined at 1.85-Å resolution. The structure reveals a DNase-I-type fold with a hydrophobic track leading to the active site that is blocked by an evolutionarily conserved motif which we term the "DK switch." Structural analysis of nSMase2 and the extended N-SMase family shows that the DK switch can adopt different conformations to reposition a universally conserved Asp (D) residue involved in catalysis. Mutation of this Asp residue in nSMase2 disrupts catalysis, allosteric activation, stimulation by phosphatidylserine, and pharmacological inhibition by the lipid-competitive inhibitor GW4869. Taken together, these results demonstrate that the DK switch regulates ceramide generation by nSMase2 and is governed by an allosteric interdomain interaction at the membrane interface.

Entities:  

Keywords:  ceramide; crystallography; enzyme; lipid; sphingomyelinase

Mesh:

Substances:

Year:  2017        PMID: 28652336      PMCID: PMC5514751          DOI: 10.1073/pnas.1705134114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  69 in total

1.  Substructure solution with SHELXD.

Authors:  Thomas R Schneider; George M Sheldrick
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-09-28

2.  Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase.

Authors:  K Hofmann; S Tomiuk; G Wolff; W Stoffel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  Depletion of microglia and inhibition of exosome synthesis halt tau propagation.

Authors:  Hirohide Asai; Seiko Ikezu; Satoshi Tsunoda; Maria Medalla; Jennifer Luebke; Tarik Haydar; Benjamin Wolozin; Oleg Butovsky; Sebastian Kügler; Tsuneya Ikezu
Journal:  Nat Neurosci       Date:  2015-10-05       Impact factor: 24.884

4.  Structural basis of the sphingomyelin phosphodiesterase activity in neutral sphingomyelinase from Bacillus cereus.

Authors:  Hideo Ago; Masataka Oda; Masaya Takahashi; Hideaki Tsuge; Sadayuki Ochi; Nobuhiko Katunuma; Masashi Miyano; Jun Sakurai
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

5.  Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation.

Authors:  M Y Kim; C Linardic; L Obeid; Y Hannun
Journal:  J Biol Chem       Date:  1991-01-05       Impact factor: 5.157

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

Review 7.  Roles and regulation of secretory and lysosomal acid sphingomyelinase.

Authors:  Russell W Jenkins; Daniel Canals; Yusuf A Hannun
Journal:  Cell Signal       Date:  2009-06       Impact factor: 4.315

8.  Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism.

Authors:  Norma Marchesini; Chiara Luberto; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2003-02-03       Impact factor: 5.157

9.  Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system.

Authors:  K A Dressler; S Mathias; R N Kolesnick
Journal:  Science       Date:  1992-03-27       Impact factor: 47.728

10.  A cell-autonomous requirement for neutral sphingomyelinase 2 in bone mineralization.

Authors:  Zohreh Khavandgar; Christophe Poirier; Christopher J Clarke; Jingjing Li; Nicholas Wang; Marc D McKee; Yusuf A Hannun; Monzur Murshed
Journal:  J Cell Biol       Date:  2011-07-25       Impact factor: 10.539

View more
  25 in total

1.  nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe-/- Mice.

Authors:  Tom Lallemand; Myriam Rouahi; Audrey Swiader; Marie-Hélène Grazide; Nancy Geoffre; Paul Alayrac; Emeline Recazens; Agnès Coste; Robert Salvayre; Anne Nègre-Salvayre; Nathalie Augé
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-05-24       Impact factor: 8.311

2.  Suppressing the intestinal farnesoid X receptor/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis.

Authors:  Qing Wu; Lulu Sun; Xiaomin Hu; Xuemei Wang; Feng Xu; Bo Chen; Xianyi Liang; Jialin Xia; Pengcheng Wang; Daisuke Aibara; Shaofei Zhang; Guangyi Zeng; Chuyu Yun; Yu Yan; Yicheng Zhu; Michael Bustin; Shuyang Zhang; Frank J Gonzalez; Changtao Jiang
Journal:  J Clin Invest       Date:  2021-05-03       Impact factor: 14.808

3.  The juxtamembrane linker in neutral sphingomyelinase-2 functions as an intramolecular allosteric switch that activates the enzyme.

Authors:  Prajna Shanbhogue; Reece M Hoffmann; Michael V Airola; Rohan Maini; David J Hamelin; Miguel Garcia-Diaz; John E Burke; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2019-03-19       Impact factor: 5.157

Review 4.  Sphingolipid metabolism in cancer signalling and therapy.

Authors:  Besim Ogretmen
Journal:  Nat Rev Cancer       Date:  2017-11-17       Impact factor: 60.716

5.  Remodeling of the interdomain allosteric linker upon membrane binding of CCTα pulls its active site close to the membrane surface.

Authors:  Daniel G Knowles; Jaeyong Lee; Svetla G Taneva; Rosemary B Cornell
Journal:  J Biol Chem       Date:  2019-09-04       Impact factor: 5.157

6.  Dietary inulin decreases circulating ceramides by suppressing neutral sphingomyelinase expression and activity in mice.

Authors:  Pan Deng; Jessie B Hoffman; Michael C Petriello; Chun-Yan Wang; Xu-Sheng Li; Maria P Kraemer; Andrew J Morris; Bernhard Hennig
Journal:  J Lipid Res       Date:  2019-10-11       Impact factor: 5.922

7.  Novel function of ceramide for regulation of mitochondrial ATP release in astrocytes.

Authors:  Ji-Na Kong; Zhihui Zhu; Yutaka Itokazu; Guanghu Wang; Michael B Dinkins; Liansheng Zhong; Hsuan-Pei Lin; Ahmed Elsherbini; Silvia Leanhart; Xue Jiang; Haiyan Qin; Wenbo Zhi; Stefka D Spassieva; Erhard Bieberich
Journal:  J Lipid Res       Date:  2018-01-10       Impact factor: 5.922

Review 8.  Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid Network.

Authors:  Jan Skácel; Barbara S Slusher; Takashi Tsukamoto
Journal:  J Med Chem       Date:  2021-01-04       Impact factor: 7.446

9.  Suppression of tau propagation using an inhibitor that targets the DK-switch of nSMase2.

Authors:  Tina Bilousova; Chris Elias; Emily Miyoshi; Mohammad Parvez Alam; Chunni Zhu; Jesus Campagna; Kanagasabai Vadivel; Barbara Jagodzinska; Karen Hoppens Gylys; Varghese John
Journal:  Biochem Biophys Res Commun       Date:  2018-04-09       Impact factor: 3.575

Review 10.  A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis.

Authors:  Brianna M Quinville; Natalie M Deschenes; Alex E Ryckman; Jagdeep S Walia
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.